Kawiak W, Pilarczyk M, Chmielewska B, Gieracz-Nazar A
Katedry i Kliniki Neurologii Akademii Medycznej, Lublinie.
Neurol Neurochir Pol. 1991 Nov-Dec;25(6):731-6.
The influence of piracetam on the level of inorganic and phospholipid phosphorus in blood of ischemic stroke patients was evaluated. In healthy patients piracetam (2G, i.v.) diminished the concentration of inorganic phosphorus and essentially lowered the content of ion connected with phospholipids. In stroke patients inorganic phosphorus was primarily enhanced and organic lowered. Treatment with piracetam lowered the concentration of both inorganic and phospholipid phosphorus in blood.
评估了吡拉西坦对缺血性中风患者血液中无机磷和磷脂磷水平的影响。在健康患者中,吡拉西坦(2克,静脉注射)降低了无机磷的浓度,并显著降低了与磷脂相关的离子含量。在中风患者中,无机磷主要升高而有机磷降低。吡拉西坦治疗降低了血液中无机磷和磷脂磷的浓度。